Home - Products - Others - Other Targets - tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate

tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate

CAS No. 1035351-07-5

tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate( —— )

Catalog No. M17122 CAS No. 1035351-07-5

tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate is an active biochemical agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 39 In Stock
5MG 39 In Stock
10MG 65 In Stock
25MG 115 In Stock
50MG 184 In Stock
100MG 269 In Stock
200MG 383 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate
  • Note
    Research use only, not for human use.
  • Brief Description
    tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate is an active biochemical agent.
  • Description
    tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate is an active biochemical agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1035351-07-5
  • Formula Weight
    202.25
  • Molecular Formula
    C9H18N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1NCC1(CNC(=O)OC(C)(C)C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Hematoxylin

    Hematoxylin is a natural product.

  • Neuropeptide Y (29-6...

    Neuropeptide Y (29-64), amide, human (TFA) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.It is showed that Neuropeptide Y (29-64), amide, human (TFA) is able to protect cortical neurons from Aβ25-35 toxicity.

  • Emoxipine

    Emoxipine is an antidepressant agent.The influence of emoxipine (2-ethyl-6-methyl-3-hydroxypyridine hydrochloride) and mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) on the content of lipid peroxidation products in peripheral blood and the dynamics of clinical symptoms of gastrointestinal tract pathology has been studied in patients of middle and senile age with atherosclerosis in the abdominal aorta.